Immediate Impact
1 from Science/Nature 51 standout
Citing Papers
Cancer immune evasion, immunoediting and intratumour heterogeneity
2025 Standout
CAR-T therapy in solid tumors
2025 Standout
Works of Jennifer McDevitt being referenced
First-in-human data of ALLO-501 and ALLO-647 in relapsed/refractory large B-cell or follicular lymphoma (R/R LBCL/FL): ALPHA study.
2020
Phase 1 Dose Escalation Study of MEDI-565, a Bispecific T-Cell Engager that Targets Human Carcinoembryonic Antigen, in Patients With Advanced Gastrointestinal Adenocarcinomas
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Jennifer McDevitt | 204 | 105 | 121 | 22 | 332 | |
| Jiaqian Wang | 178 | 59 | 115 | 27 | 354 | |
| Melanie Hullings | 185 | 58 | 99 | 15 | 360 | |
| Wenjie Gong | 201 | 92 | 104 | 22 | 306 | |
| Milim Kim | 173 | 49 | 91 | 26 | 363 | |
| George Mo | 158 | 79 | 86 | 17 | 318 | |
| D. Violot | 105 | 20 | 120 | 15 | 345 | |
| Pierre‐Marie Morice | 228 | 31 | 95 | 20 | 359 | |
| Ji Won Woo | 201 | 46 | 75 | 18 | 326 | |
| P. Schmiegelow | 132 | 85 | 142 | 25 | 343 | |
| Eggermont Am | 214 | 88 | 108 | 12 | 315 |
All Works
Loading papers...